Cours Med Biogene Inc Toronto S.E.
Actions
MBI
CA58402B1076
Recherche biotechnologique et médicale
CA 2022 | - | CA 2023 | - | Capitalisation | 130 k 179 k 116 k |
---|---|---|---|---|---|
Résultat net 2022 | - 0 0 | Résultat net 2023 | - 0 0 | VE / CA 2022 | - |
Trésorerie nette 2022 | 407 559,35 362,56 | Trésorerie nette 2023 | 713 979,9 635,14 | VE / CA 2023 | - |
PER 2022 |
-4,96
x | PER 2023 |
-2,24
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 45,35% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Iain Weir-Jones
CEO | Chief Executive Officer | - | 05/09/14 |
Ibrahim Ghobrial
DFI | Director of Finance/CFO | - | 05/09/14 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Toby Weir-Jones
BRD | Director/Board Member | - | 05/09/14 |
Iain Weir-Jones
CEO | Chief Executive Officer | - | 05/09/14 |
David Diebolt
BRD | Director/Board Member | - | 05/09/14 |
Varia. 1 janv. | Capi. | |
---|---|---|
-43,39% | 7,73 Md | |
+11,68% | 3,7 Md | |
+0,37% | 2,28 Md | |
-21,21% | 1,99 Md | |
-23,77% | 1,6 Md | |
+18,25% | 739 M | |
-10,04% | 687 M | |
-36,12% | 461 M | |
-4,47% | 279 M |